Detalhe da pesquisa
1.
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer.
Cancer
; 118(13): 3283-93, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22072307
2.
Health-related quality of life outcomes of docetaxel/carboplatin combination therapy vs. sequential therapy with docetaxel then carboplatin in patients with relapsed, platinum-sensitive ovarian cancer: results from a randomized clinical trial.
Gynecol Oncol
; 123(3): 505-10, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21945310